LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha.
LMP-1, an Epstein-Barr virus membrane protein expressed during latent infection, has oncogenic properties, as judged from its ability to transform B lymphocytes and rodent fibroblasts. LMP-1 induces the expression of bcl2, an oncogene which protects cells from apoptosis, as well as of genes encoding...
Sábháilte in:
| Foilsithe in: | J Virol |
|---|---|
| Príomhchruthaitheoirí: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
American Society for Microbiology (ASM)
1995
|
| Ábhair: | |
| Rochtain ar líne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188885/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7884865/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.4.2168-2174.1995 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|